세계의 유전자 검사 시장 보고서(2025년)
Genetic Testing Global Market Report 2025
상품코드 : 1824498
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

유전자 검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.4%로 성장할 전망이며, 298억 7,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 정부 지원 증가, 유전성 질환의 유병률 상승, 노년 인구 증가, 만성 질환의 유병률 상승에 기인할 것으로 예측됩니다. 예측 기간 주요 동향으로는 유전 상담 및 차세대 유전자 검사 개발을 지원하는 정보학 프로그램 등 새로운 프로그램 도입, 기술의 진보, 소비자 직접 유전자 검사 개시 등을 들 수 있습니다.

향후 5년간의 성장률 9.4%라고 하는 예측은 이 시장 전회 예측으로부터 0.4%라고 하는 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 관세의 상승은 아이슬란드와 벨기에에서 공급되는 캐리어 스크리닝 검사 및 출생 전 유전자 키트의 가격을 밀어 올리고, 자기 부담액을 악화시켜, 생식 의료의 선택지를 제한하는 것으로, 미국의 환자에게 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

유전성 질환의 유병률 증가는 향후 유전자 검사 시장의 성장을 이끌 것으로 예측됩니다. 유전성 질환은 출생 시에 발현하는 경우도 있고, 시간이 지남에 따라 발병할 수도 있으며, 유전자 검사는 이러한 문제를 진단하고 암 등의 질병의 발병 가능성을 분석하는 데 도움이 됩니다. 예를 들어 2024년 스위스에 본부를 둔 정부 간 기관인 세계보건기구(WHO)의 보고서에 따르면 유전성 질환과 선천성 이상은 출생아의 2%에서 5%에 영향을 미치고, 소아과 입원의 30%를 차지하며, 선진국에서 소아 사망의 약 50%에 기여하고 있습니다. 이와 같이 유전성 질환의 유병률 상승이 유전자 검사 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Genetic testing is a type of medical examination that seeks alterations in genes, proteins, or chromosomes. The results of a genetic test can identify a genetic ailment and determine a person's risk of developing a genetic disorder. This testing is utilized to confirm specific genetic disorders in children based on physical signs and symptoms.

The main types of genetic testing include predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomic testing, and other types. Predictive tests belong to a new and rapidly expanding class of medical tests that differ fundamentally from traditional diagnostic examinations. Various technologies are involved in genetic testing, such as cytogenetic testing, biochemical testing, and molecular testing. It is applied in several areas, including cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others, with end users including hospitals and clinics, diagnostic laboratories and centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genetic testing market research report is one of a series of new reports from The Business Research Company that provides genetic testing market statistics, including global market size, regional shares, competitors with a genetic testing market share, detailed genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the genetic testing industry. This genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genetic testing market size has grown strongly in recent years. It will grow from $19.1 billion in 2024 to $20.84 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing healthcare expenditure, a rise in cancer prevalence, an increase in demand for personalized medicine, and the emergence of novel infectious diseases.

The genetic testing market size is expected to see strong growth in the next few years. It will grow to $29.87 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing government support, rising prevalence of genetic disorders, rising geriatric population, and increase in chronic disease prevalence. Major trends in the forecast period include introducing new programs such as genetic counseling and informatics programs that will assist in developing the next generation of genetic testing, technological advancement, and launching direct-to-consumer genetic tests.

The forecast of 9.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of carrier screening tests and prenatal genetic kits sourced from Iceland and Belgium, exacerbating out-of-pocket expenses and limiting reproductive health options. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of genetic disorders is expected to drive the growth of the genetic testing market in the future. Genetic disorders can manifest at birth or develop over time, and genetic testing is instrumental in diagnosing these issues and providing insights into the likelihood of developing conditions such as cancer. For example, in 2024, a report from the World Health Organization, a Switzerland-based intergovernmental organization, indicated that genetic disorders and congenital abnormalities affect 2% to 5% of live births and account for 30% of pediatric hospital admissions, contributing to about 50% of childhood deaths in industrialized countries. Thus, the rising prevalence of genetic disorders is fueling the growth of the genetic testing market.

The escalating number of chronic diseases is expected to further drive the growth of the genetic testing market. Chronic diseases, characterized by prolonged durations often lasting a person's lifetime, necessitate informed decisions for disease prevention, management, and treatment. Genetic testing plays a crucial role in empowering individuals and healthcare providers to make such informed decisions, particularly in the context of chronic diseases. Globally, chronic diseases account for 74% of 41 million annual deaths, with cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes being major contributors, according to the World Health Organization in September 2023. Hence, the increasing prevalence of chronic diseases is a key driver of the genetic testing market.

Direct-to-consumer genetic tests represent a significant trend gaining momentum in the genetic testing market. Known as at-home DNA tests, these direct-to-consumer deoxyribonucleic acid (DNA) tests allow individuals to collect samples at home and send them off for analysis to evaluate their genetic risk for specific diseases. Home-based genetic testing analyzes individuals' DNA to identify gene variations that may increase the likelihood of developing certain medical conditions. For instance, in 2022, DNALabs, an India-based company focused on genetic testing solutions to advance personalized medicine, launched At-Home Genetic Testing Solutions. This service empowers individuals to make informed decisions with just a simple cheek swab using an at-home DNA collection kit, catering to both consumers taking charge of their health and healthcare professionals aiming to tailor optimal treatments for their patients.

The introduction of new programs is a significant trend gaining traction in the genetic testing market. Companies in this sector are emphasizing the expansion of diversity in healthcare through innovative genetic counseling and informatics initiatives that will aid in developing the next generation of genetic testing. For example, in June 2022, Illumina, Inc., a US-based company renowned for its cutting-edge technologies in genetic variation analysis, launched a research test co-developed with Merck aimed at providing deeper insights into the tumor genome. This initiative builds on Illumina's dedication to enabling comprehensive genomic profiling and bolstering research essential for precision medicine in oncology. The widely utilized TruSight Oncology 500 assay has now incorporated the evaluation of a novel genetic signature. This offering will be available globally, excluding the United States and Japan, and will assist researchers in gaining a more profound understanding of the tumor genome by identifying genetic alterations linked to homologous recombination deficiency (HRD).

In January 2022, Exact Sciences, a US-based molecular diagnostics company specializing in genetic testing products, acquired Prevention Genetics in a deal valued at $190 million. Through this acquisition, Exact Sciences intends to expand hereditary cancer testing access to more patients. Prevention Genetics, a US-based company, produces clinical DNA (genetic) tests for inherited genetic conditions.

Major companies operating in the genetic testing market include Myriad Genetics Inc, Illumina Inc, Abbott Laboratories, Eurofins Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Qiagen NV, Thermo Fisher Scientific Inc., BioRad Laboratories Inc., BGI, Berry Genomics Co. ltd, Daan Gene Co. Ltd, Annoroad Gene Technology Co. Ltd, WuXi PharmaTech, Igenomix, Circle DNA, Centogene, Curetis, Cytena, Probably Genetic, Genome Biologics, WuXi NextCODE, Genomtec, Testgene, Evogen Lab, Phosphorus, Helix, Sequencing, 10x Genomics, Quantgene, Virica Biotech, DNALabs, Deep Genomics, SGS Mexico, Hologic Inc, 23andMe Inc, Middle East Testing Services L.L.C, Molecular Biology & Genetics Laboratory, Freiburg Medical Laboratory Middle East, IVI MIDDLE EAST FERTILITY CLINIC, Bio Certica

North America was the largest region in the genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The genetic testing market includes revenues earned by entities by chromosomal genetic tests, molecular genetic tests (or gene tests), biochemical tests, newborn screening, and diagnostic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Genetic Testing Market Characteristics

3. Genetic Testing Market Trends And Strategies

4. Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genetic Testing Growth Analysis And Strategic Analysis Framework

6. Genetic Testing Market Segmentation

7. Genetic Testing Market Regional And Country Analysis

8. Asia-Pacific Genetic Testing Market

9. China Genetic Testing Market

10. India Genetic Testing Market

11. Japan Genetic Testing Market

12. Australia Genetic Testing Market

13. Indonesia Genetic Testing Market

14. South Korea Genetic Testing Market

15. Western Europe Genetic Testing Market

16. UK Genetic Testing Market

17. Germany Genetic Testing Market

18. France Genetic Testing Market

19. Italy Genetic Testing Market

20. Spain Genetic Testing Market

21. Eastern Europe Genetic Testing Market

22. Russia Genetic Testing Market

23. North America Genetic Testing Market

24. USA Genetic Testing Market

25. Canada Genetic Testing Market

26. South America Genetic Testing Market

27. Brazil Genetic Testing Market

28. Middle East Genetic Testing Market

29. Africa Genetic Testing Market

30. Genetic Testing Market Competitive Landscape And Company Profiles

31. Genetic Testing Market Other Major And Innovative Companies

32. Global Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genetic Testing Market

34. Recent Developments In The Genetic Testing Market

35. Genetic Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기